SOURCE: Novo Nordisk A/S

June 30, 2008 08:46 ET

Novo Nordisk A/S -- Total voting rights

BAGSVAERD, DENMARK--(Marketwire - June 30, 2008) - Total number of voting rights and share capital in Novo Nordisk A/S as of 30 June 2008.


In accordance with Section 6 of the Danish Statutory Order on Issuers Disclosure Obligations, Novo Nordisk is required to publish the total number of voting rights and the size of the share capital in Novo Nordisk as per the end of the month where changes have occurred.

Referring to Stock Exchange Announcement no 35/2008 dated 13 June 2008, please find below a statement regarding the total number of voting rights and share capital in Novo Nordisk as per 30 June 2008.


+---------------------------------------------------------------+
|          | Number of shares | Nominal value | Number of votes |
|          |   (nominal value |         (DKK) |                 |
|          |           DKK 1) |               |                 |
|----------+------------------+---------------+-----------------|
| A shares |                  |               |                 |
|          |      107,487,200 |   107,487,200 | 107,487,200,000 |
|----------+------------------+---------------+-----------------|
| B shares |                  |               |                 |
|          |      526,512,800 |   526,512,800 |  52,651,280,000 |
+---------------------------------------------------------------+


Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,300 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

For further information please contact:

Media:                 Investors:

Outside North America: Outside North America:
Elin K Hansen          Mads Veggerby Lausten
Tel: (+45) 4442 3450   Tel: (+45) 4443 7919
ekh@novonordisk.com    mlau@novonordisk.com

                       Hans Rommer
                       Tel: (+45) 4442 4765
                       hrmm@novonordisk.com

In North America:      In North America:
Sean Clements          Christian Qvist Frandsen
Tel: (+1) 609 514 8316 Tel: (+1) 609 919 7937
secl@novonordisk.com   cqfr@novonordisk.com

Stock Exchange Announcement no 40 / 2008





Copyright © Hugin AS 2008. All rights reserved.

Contact Information